Suppr超能文献

多功能氧化吲哚作为选择性PI3Kδ抑制剂的优化

Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors.

作者信息

Methot Joey L, Achab Abdelghani, Christopher Matthew, Zhou Hua, McGowan Meredeth A, Trotter B Wesley, Fradera Xavier, Lesburg Charles A, Goldenblatt Peter, Hill Armetta, Chen Dapeng, Otte Karin M, Augustin Martin, Shah Sanjiv, Katz Jason D

机构信息

Discovery Chemistry, Computational and Structural Chemistry, In Vitro Pharmacology, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Proteros Biostructures, Martinsried 82152, Germany.

出版信息

ACS Med Chem Lett. 2020 Nov 19;11(12):2461-2469. doi: 10.1021/acsmedchemlett.0c00441. eCollection 2020 Dec 10.

Abstract

The 3,3-disubstituted oxindole moiety is a versatile and rigid three-dimensionally shaped scaffold. When engineered with a purine hinge-binding core, exceptionally selective PI3Kδ kinase inhibitors were discovered by exploiting small differences in isoform selectivity pockets. Crystal structures of early lead bound to PI3Kδ and PI3Kα helped rationalize the high selectivity observed with . By attenuating the lypophilicity and metabolic liabilities of an oxindole moiety, we improved the preclinical species PK and solubility and reduced adenosine uptake activity. The excellent potency and kinome selectivity of 7-azaoxindole and spirooxindole , together with a low plasma clearance and good half-life in rat and dog, supported a low once-daily predicted human dose.

摘要

3,3-二取代氧化吲哚部分是一种通用且刚性的三维形状支架。当与嘌呤铰链结合核心进行工程化设计时,通过利用同工型选择性口袋中的微小差异,发现了具有异常选择性的PI3Kδ激酶抑制剂。早期先导化合物与PI3Kδ和PI3Kα结合的晶体结构有助于解释所观察到的高选择性。通过减弱氧化吲哚部分的亲脂性和代谢负担,我们改善了临床前物种的药代动力学和溶解度,并降低了腺苷摄取活性。7-氮杂氧化吲哚和螺氧化吲哚的优异效力和激酶组选择性,以及在大鼠和犬中的低血浆清除率和良好半衰期,支持了每日一次的低预测人体剂量。

相似文献

1
Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors.多功能氧化吲哚作为选择性PI3Kδ抑制剂的优化
ACS Med Chem Lett. 2020 Nov 19;11(12):2461-2469. doi: 10.1021/acsmedchemlett.0c00441. eCollection 2020 Dec 10.
5
From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.从PIM1到PI3Kδ,经由GSK3β:通过激酶组进行靶点跳跃
ACS Med Chem Lett. 2017 Sep 7;8(10):1093-1098. doi: 10.1021/acsmedchemlett.7b00296. eCollection 2017 Oct 12.

本文引用的文献

7
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow.PI3K抑制剂在B细胞淋巴瘤中的临床应用:现状与未来。
Expert Rev Anticancer Ther. 2017 Mar;17(3):271-279. doi: 10.1080/14737140.2017.1285702. Epub 2017 Feb 6.
10
PI3K inhibitors in inflammation, autoimmunity and cancer.炎症、自身免疫和癌症中的PI3K抑制剂
Curr Opin Pharmacol. 2015 Aug;23:82-91. doi: 10.1016/j.coph.2015.05.017. Epub 2015 Jun 18.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验